B. Stannard

发表

Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

M. Reitman, D. Leroith, S. Yakar, 2003, Diabetes.

Sphingosine 1-Phosphate Stimulates Tyrosine Phosphorylation of Crk*

S. Spiegel, D. Beitner-Johnson, D. Leroith, 1997, The Journal of Biological Chemistry.

Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.

D. Leroith, A. Scrimgeour, B. Stannard, 1997, Endocrinology.

Role of the IGF-I receptor in mutagenesis and tumor promotion.

D. Leroith, L. Helman, T. Kalebic, 1997, Journal of Endocrinology.

Differential effect of inhibitors of oligosaccharide processing on the secretion of thyrotropin from dispersed rodent pituitary cells.

B. Weintraub, N. R. Thotakura, N. Gesundheit, 1989, Biochemical and biophysical research communications.

Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3).

C. Roberts, D. Leroith, B. Stannard, 1993, The Journal of biological chemistry.

Insulin-like Growth Factor-I Inhibits the Stress-activated Protein Kinase/c-Jun N-terminal Kinase*

D. Le Roith, Y. Okubo, B. Stannard, 1998, The Journal of Biological Chemistry.

Replacement of Tyrosine 1251 in the Carboxyl Terminus of the Insulin-like Growth Factor-I Receptor Disrupts the Actin Cytoskeleton and Inhibits Proliferation and Anchorage-independent Growth*

D. Leroith, A. Scrimgeour, A. Koval, 1998, The Journal of Biological Chemistry.

Metabolic effects of IGF-I deficiency: lessons from mouse models.

D. Leroith, Hong Zhao, S. Yakar, 2005, Pediatric endocrinology reviews : PER.

Regulation of insulin-like growth factor I receptor gene expression in normal and pathological states.

H. Werner, C. Roberts, D. Leroith, 1991, Advances in experimental medicine and biology.

Paradoxical biological effects of overexpressed insulin‐like growth factor‐1 receptors in chinese hamster ovary cells

Simeon I. Taylor, C. Roberts, D. Leroith, 1993, Journal of cellular physiology.

The Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor

B. Burguera, H. Werner, C. Roberts, 1989 .

Protection against hypoxic–ischemic injury in transgenic mice overexpressing Kir6.2 channel pore in forebrain

D. Leroith, S. Vannucci, C. Mobbs, 2004, Molecular and Cellular Neuroscience.

Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death

D. Leroith, H. Arima, A. Basile, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Structural and functional analysis of the insulin-like growth factor I receptor gene promoter.

H. Werner, C. Roberts, D. Leroith, 1992, Molecular endocrinology.

Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis.

C. Roberts, D. Leroith, B. Stannard, 1995, Endocrinology.

Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats.

C. Roberts, D. Leroith, F. Cassorla, 1993, Endocrinology.

Normal growth and development in the absence of hepatic insulin-like growth factor I.

D. Leroith, S. Yakar, D. Accili, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

M. Bouxsein, D. Leroith, Hong Zhao, 2004, The Journal of clinical investigation.

Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle.

R. Farrar, J. Dupont, D. Le Roith, 2002, The Journal of clinical investigation.

Precursor—product relationships in the biosynthesis and secretion of thyrotropin and its subunits by mouse thyrotropic tumor cells

B. Weintraub, B. Stannard, 1978, FEBS letters.

Relationship of glycosylation to de novo thyroid-stimulating hormone biosynthesis and secretion by mouse pituitary tumor cells.

B. Weintraub, D. Linnekin, B. Stannard, 1980, The Journal of biological chemistry.

Combination of ectopic and standard human glycoprotein hormone alpha with beta subunits: discordance of immunologic and receptor-binding activity.

B. Weintraub, B. Stannard, S. Rosen, 1977, Endocrinology.

Differential processing and regulation of thyroid-stimulating hormone subunit carbohydrate chains in thyrotropic tumors and in normal and hypothyroid pituitaries.

B. Weintraub, C. Ronin, B. Stannard, 1985, Biochemistry.

Glycosylation and posttranslational processing of thyroid-stimulating hormone: clinical implications.

B. Weintraub, T. Taylor, N. Gesundheit, 1985, Recent progress in hormone research.

Glycosylation and processing of high-mannose oligosaccharides of thyroid-stimulating hormone subunits: comparison to nonsecretory cell glycoproteins.

B. Weintraub, J. Magner, C. Ronin, 1984, Biochemistry.

Glycosylation of thyroid-stimulating hormone in pituitary tumor cells: influence of high mannose oligosaccharide units on subunit aggregation, combination, and intracellular degradation.

B. Weintraub, B. Stannard, L. Meyers, 1983, Endocrinology.

Characterization and charge distribution of the asparagine-linked oligosaccharides on secreted mouse thyrotropin and free alpha-subunits.

B. Weintraub, N. Gesundheit, R. Winston, 1989, Endocrinology.

Differential carbohydrate processing and secretion of thyrotropin and free alpha subunit. Effects of 1-deoxynojirimycin.

J. Burnside, B. Weintraub, N. Gesundheit, 1988, The Journal of biological chemistry.

The conformation of polyriboadenylic acid at low temperature and neutral pH. A single‐stranded rodlike structure

G. Felsenfeld, B. Stannard, 1975, Biopolymers.

The Proto-oncogene Product c-Crk Associates with Insulin Receptor Substrate-1 and 4PS

D. Leroith, Ling-mei Wang, J. Pierce, 1996, The Journal of Biological Chemistry.

Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice.

M. Reitman, O. Gavrilova, S. Chua, 2004, Endocrinology.

Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.

V. Barr, D. Le Roith, Valarie Barr, 2002, Cancer research.

Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene.

H. Werner, C. Roberts, D. Leroith, 1990, Biochemical and biophysical research communications.

Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.

C T Roberts, C. Roberts, D. Leroith, 1994, Molecular endocrinology.

Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats.

M. Phillip, H. Werner, C. Roberts, 1994, Journal of molecular endocrinology.

Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones.

D. Leroith, R. Fuchs-Young, J. C. Barrett, 2006, Endocrinology.

Changes in the sialylation and sulfation of secreted thyrotropin in congenital hypothyroidism.

B. Weintraub, N. R. Thotakura, N. Gesundheit, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.

C. Roberts, D. Leroith, L. Helman, 1996, Endocrinology.

Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function.

C. Roberts, D. Leroith, B. Stannard, 1994, The Journal of biological chemistry.

Alterations in the glycosylation of secreted thyrotropin during ontogenesis. Analysis of sialylated and sulfated oligosaccharides.

B. Weintraub, N. Gesundheit, B. Stannard, 1989, Journal of Biological Chemistry.

Experimental Diabetes Increases Insulinlike Growth Factor I and II Receptor Concentration and Gene Expression in Kidney

B. Burguera, H. Werner, C. Roberts, 1990, Diabetes.

In vitro and in vivo responses to short‐term recombinant human insulin‐like growth factor‐1 (IGF‐I) in a severely growth‐retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene

H. Werner, D. Leroith, S. Malozowski, 1999, Clinical endocrinology.

Cytokines and growth factors modulate cell growth and insulin‐like growth factor binding protein secretion by the human salivary cell line (HSG)

D. Leroith, J. Shemer, B. Stannard, 1995, Journal of cellular physiology.

Insulin-like growth factors.

C. Roberts, D. Leroith, B. Stannard, 1992, Biological signals.